Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs).
Prasetyanti PR, Capone E, Barcaroli D, D'Agostino D, Volpe S, Benfante A, van Hooff S, Iacobelli V, Rossi C, Iacobelli S, Medema JP, De Laurenzi V, Sala G. Prasetyanti PR, et al. Among authors: iacobelli v, iacobelli s. Oncotarget. 2015 Jul 10;6(19):16902-11. doi: 10.18632/oncotarget.4642. Oncotarget. 2015. PMID: 26160848 Free PMC article.
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody-Drug Conjugates.
Giansanti F, Capone E, Ponziani S, Piccolo E, Gentile R, Lamolinara A, Di Campli A, Sallese M, Iacobelli V, Cimini A, De Laurenzi V, Lattanzio R, Piantelli M, Ippoliti R, Sala G, Iacobelli S. Giansanti F, et al. Among authors: iacobelli v, iacobelli s. J Control Release. 2019 Jan 28;294:176-184. doi: 10.1016/j.jconrel.2018.12.018. Epub 2018 Dec 13. J Control Release. 2019. PMID: 30553852 Free article.
Antibody-Drug Conjugates: The New Frontier of Chemotherapy.
Ponziani S, Di Vittorio G, Pitari G, Cimini AM, Ardini M, Gentile R, Iacobelli S, Sala G, Capone E, Flavell DJ, Ippoliti R, Giansanti F. Ponziani S, et al. Among authors: iacobelli s. Int J Mol Sci. 2020 Jul 31;21(15):5510. doi: 10.3390/ijms21155510. Int J Mol Sci. 2020. PMID: 32752132 Free PMC article. Review.
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma.
Capone E, Lamolinara A, Pastorino F, Gentile R, Ponziani S, Di Vittorio G, D'Agostino D, Bibbò S, Rossi C, Piccolo E, Iacobelli V, Lattanzio R, Panella V, Sallese M, De Laurenzi V, Giansanti F, Sala A, Iezzi M, Ponzoni M, Ippoliti R, Iacobelli S, Sala G. Capone E, et al. Among authors: iacobelli v, iacobelli s. Cancers (Basel). 2020 Oct 15;12(10):2989. doi: 10.3390/cancers12102989. Cancers (Basel). 2020. PMID: 33076448 Free PMC article.
466 results